Evidence map›Paper›PMID 24231619›Full record

ArticleNature chemical biology2013

Adaptive immune activation: glycosylation does matter.

Margreet A Wolfert, Geert-Jan Boons

Open access · bronzeAbstract read
In one paragraph

Article in Nature chemical biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 1 synthesis or guideline pooled it, 324 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Glycomics Meets Oncology: The Role of Mass Spectrometry in Cancer Research.Advances in experimental medicine and biology · 2026
    Review
  11. Emerging Mechanistic Links Between Fucosylation and Senescence in Lung Diseases.Journal of respiratory biology and translational medicine · 2026
    Article
  12. Article
  13. Metabolomic profiling ofmSystems · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Margreet A WolfertComplex Carbohydrate Research Center, Athens, Georgia, USA.
Geert-Jan Boons

Funding

Synthesis/Immunological Properties of Lewis AntigensR01CA088986 · NCI · UNIVERSITY OF GEORGIA (UGA) · PI BOONS, GEERT-JAN · 2002 to 2015
$4.6M
Synthetic Oligosaccharides for Probing Infection and Innate ImmunityR01GM061761 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI BOONS, GEERT-JAN · 2000 to 2014
$4.5M
Novel chemoenzymatic approaches for the synthesis of complex glycansR01GM090269 · NIGMS · UNIVERSITY OF GEORGIA · PI BOONS, GEERT-JAN · 2009 to 2016
$1.8M
NCI NIH HHS R01 CA088986NCI NIH HHS R01CA88986NIGMS NIH HHS R01 GM061761NIGMS NIH HHS R01GM061761NIGMS NIH HHS R01 GM090269NIGMS NIH HHS R01GM090269
6 · The paper itself

Abstract

Major histocompatibility complex (MHC) class I and II are glycoproteins that can present antigenic peptides at the cell surface for recognition and activation of circulating T lymphocytes. Here, the importance of the modification of protein antigens by glycans on cellular uptake, proteolytic processing, presentation by MHC and subsequent T-cell priming is reviewed. Antigen glycosylation is important for a number of diseases and vaccine design. All of the key proteins involved in antigen recognition and the orchestration of downstream effector functions are glycosylated. The influence of protein glycosylation on immune function and disease is covered.

Indexed as

Adaptive ImmunityAntigensGlycoproteinsGlycosylationMajor Histocompatibility ComplexVaccinesAntigensGlycoproteinsVaccines

Identifiers

PMID24231619
PMCPMC3966069
OpenAlexW2077312152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.